TY  - BOOK
AU  - Niazi,Sarfaraz
TI  - Handbook of pharmaceutical manufacturing formulations
SN  - 9781315102948
AV  - RS200 
U1  - 615.19 23
PY  - 2019///
CY  - Boca Raton
PB  - CRC Press
KW  - Drugs
KW  - Dosage forms
N1  - Previous edition: New York: Informa Healthcare, 2009; <P><STRONG>Part I. Regulatory and Manufacturing Guidelines</STRONG></P><P>Chapter 1. U.S. FDA Good Manufacturing Practices</P><P>Chapter 2. Guideline on the Common Technical Document for the Registration of Pharmaceuticals for Human Use</P><P>Chapter 3. Process Validation: General Principles and Practices</P><P>Chapter 4. Bioequivalence Regulatory Compliance</P><P>Chapter 5. Bioequivalence Regulatory Review Process and Audit</P><P>Chapter 6. EU Guidelines to Good Manufacturing Practice: Active Drug Substance</P><P>Chapter 7. FDA Pre-approval Inspections</P><P>Chapter 8. Formulation Factors in Uncompressed Dosage Forms</P><P>Chapter 9: Solid-State Properties.</P><P>Chapter 10: Formulation of Flavor.</P><P><STRONG>Part II. Manufacturing Formulations</STRONG></P><P>Uncompressed Solids Formulations</P><P><STRONG>Part III. Commercial Pharmaceutical Formulations.</STRONG></P><P>Commercial Pharmaceutical Formulations.</P>
UR  - https://www.taylorfrancis.com/books/9781315102948
UR  - http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
ER  -